Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019

Camden, Andi; Ray, Joel G.; To, Teresa; Gomes, Tara; Bai, Li; Guttmann, Astrid

doi:10.1001/jamanetworkopen.2020.37388

Cited by 14 publications

(15 citation statements)

References 6 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…pioid use in pregnancy is a public health concern, [1][2][3][4][5] with 2%-4% of pregnancies exposed to prescribed opi oid analgesics. [6][7][8] Opioid analgesics cross the placenta and have potential to cause fetal harm.…”

mentioning

confidence: 99%

Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study

Bowie

Werler

Vélez

et al. 2022

CMAJ

Self Cite

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study

Bowie

Werler

Vélez

et al. 2022

CMAJ

Self Cite

View full text Add to dashboard Cite

show abstract

“…2,8,13 However, it may be difficult to identify higher risk groups in studies where POE is defined broadly. For example, although most people with POE are prescribed short courses of opioid analgesics in pregnancy, 2 those with long-term opioid analgesic use are at greater risk of developing OUD, 14 which may go undiagnosed because of stigma associated with drug use during pregnancy. Previous studies have identified factors associated with various types of opioid use in pregnancy using variable-centered approaches 5,11,13 (eg, regression analysis) that focus on associations between variables across people with an underlying assumption that variable associations are the same among all members in a population.…”

Section: Introductionmentioning

confidence: 99%

Categorization of Opioid Use Among Pregnant People and Association With Overdose or Death

Camden

Ray

et al. 2022

JAMA Netw Open

Self Cite

View full text Add to dashboard Cite

IMPORTANCEEarly identification of people who use opioids in pregnancy may improve health outcomes for pregnant people and infants. However, characterization of diverse circumstances surrounding type of opioid use and indications for opioid use are lacking. OBJECTIVE To develop clinically distinct groups of people who use opioids in pregnancy and to evaluate their association with drug overdose or death up to 1 year post partum. DESIGN, SETTING, AND PARTICIPANTS This is a population-based, repeated cross-sectional study conducted in Ontario, Canada, with participants who used opioids in pregnancy who had a live birth

show abstract

“…Furthermore, women in the United States have also reported tobacco use (11.6%), heavy alcohol use (9.9%), and illicit substance use (5.4%) during pregnancy 3 . Canadian women have also reported cannabis use (3.1%) and alcohol use (10%) during pregnancy 4,5 . Opioid use during pregnancy is likewise a problem in Canada 4,6 .…”

Section: Substance Use In the Perinatal Periodmentioning

confidence: 99%

“…Canadian women have also reported cannabis use (3.1%) and alcohol use (10%) during pregnancy 4,5 . Opioid use during pregnancy is likewise a problem in Canada 4,6 . Despite an overall decrease in prenatal opioid exposure from 2014 to 2019, Camden et al 6 discovered that the annual prevalence of prenatal opioid exposure was 4.5% of all hospital births in 2019, with the highest rates among women aged 20 to 24 years.…”

Section: Substance Use In the Perinatal Periodmentioning

confidence: 99%

Provider Characteristics Associated with Trust When Caring for Women Experiencing Substance Use Disorders in the Perinatal Period

Renbarger

Trainor

Place

et al. 2022

J Midwife Womens Health

View full text Add to dashboard Cite

Introduction Women experiencing substance use disorders (SUD) have often reported challenges in their relationships with health care providers during the perinatal period that served as a barrier to care. Establishing trust is an important aspect in forming positive relationships. The purpose of this study was to identify provider characteristics associated with the development of trust when caring for women experiencing SUD during the perinatal period. Methods A systematic search was conducted using the databases of CINAHL, APA PsychINFO, and PubMed along with a manual search of Google Scholar between the years of 2000‐2021. Studies were included if they were (1) original qualitative research; (2) published in English; (3) peer reviewed; (4) from the perspective of women experiencing SUD; (5) included descriptions of positive health care interactions between women experiencing SUD in the perinatal period and their health care providers; and (6) conducted in the United States or Canada. The studies were assessed for quality and validity using 10 criteria from the Joanne Briggs Institute critical appraisal checklist for qualitative research. Results Findings from 21 qualitative studies were synthesized using a thematic synthesis approach and revealed 3 overarching themes that included 7 descriptive subthemes which identified provider characteristics associated with trust. The 7 descriptive subthemes included: developing rapport with women, demonstrating caring behaviors, including women in care, understanding women's SUD treatment efforts, reassuring women, delivering competent care, and educating women. Discussion Participants’ accounts of trusting interactions with health care providers occurred when providers viewed women approvingly, affirmed their treatment efforts and maternal abilities, and delivered competent care that was knowledgeable of issues associated with SUD. The findings suggest the importance of confronting implicit biases, integrated care, and fostering a stigma‐free and trauma‐informed working environment.

show abstract

Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019

Abstract: This population-based cohort study assesses the prevalence of opioid use in pregnant women in Ontario, Canada, from 2014 through 2019.

Cited by 14 publications

References 6 publications

Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study

Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study

Categorization of Opioid Use Among Pregnant People and Association With Overdose or Death

Provider Characteristics Associated with Trust When Caring for Women Experiencing Substance Use Disorders in the Perinatal Period

Contact Info

Product

Resources

About